Coherus Granted Permanent, Product-Specific Q-Code for CIMERLI® (ranibizumab-eqrn) from the Centers for Medicare and Medicaid Services
– Q-Code assigned to CIMERLI® for Medicare claims processing effective for dates of service on…
Month: February 2023
Coherus Granted Permanent, Product-Specific Q-Code for CIMERLI® (ranibizumab-eqrn) from the Centers for Medicare and Medicaid Services
– Q-Code assigned to CIMERLI® for Medicare claims processing effective for dates of service on…
Pyxis Oncology to Participate in the Virtual 2023 SVB Securities Global Biopharma Conference
CAMBRIDGE, Mass., Feb. 13, 2023 (GLOBE NEWSWIRE) — Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical…
Williams Appoints Carri Lockhart to Board of Directors
TULSA, Okla.–(BUSINESS WIRE)–Williams (NYSE: WMB) today announced that its Board of Directors has appointed Carri…
Nasal Spray Significantly Accelerates Respiratory Virus Clearance in Phase 2a Clinical Study
— Post hoc analyses found a statistically significant reduction in the duration of flu infection…
Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2022 Financial Results
SAN DIEGO, Feb. 13, 2023 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (the “Company” or “Fate…
Akari Therapeutics Announces Acceleration of the Phase 3 Clinical Trial of Nomacopan for Treatment of Pediatric HSCT-TMA into Pivotal Part B and Addition of a New Pipeline Program Developing Nomacopan for HSCT-TMA in Adults
Based on Type C guidance requested and received from the U.S. Food and Drug Administration…
Acumen Pharmaceuticals Completes Enrollment in Phase 1 Trial of ACU193, First Monoclonal Antibody Developed to Selectively Target Toxic Aβ Oligomers in Patients with Early Alzheimer’s Disease
Topline results including safety and proof-of-mechanism data expected in third quarter of 2023 CHARLOTTESVILLE, Va….
Benitec Biopharma Releases Second Quarter 2023 Financial Results and Provides Operational Update
First subject enrolled into the OPMD clinical development program HAYWARD, Calif., Feb. 13, 2023 (GLOBE…
Ocuphire Announces FDA Acceptance of New Drug Application and PDUFA Date of September 28, 2023 for Nyxol® Eye Drops for Reversal of Mydriasis
If Approved Later This Year, Nyxol Could be the Only Commercially Available Eye Drop for…
Amarin Shareholders Invited to Webcast with Board and Management Team
— Board and Management Team to Answer Shareholder Questions — DUBLIN, Ireland and BRIDGEWATER, N.J.,…
BridgeBio Pharma to Host Educational Roundtable with Esteemed Achondroplasia Expert on February 16, 2023
PALO ALTO, Calif., Feb. 13, 2023 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio”…
Aleafia Health Announces Q3 FY2023 Results, International Expansion and Second Quarter of Profitability
2nd consecutive quarter of positive Adjusted EBITDA1 4% Adjusted EBITDA margin2 places company in top…
Hillstream BioPharma Signs Exclusive Option Agreement with Applied Biomedical Science Institute (ABSI) to License Technology for HER2 and HER3 to be Developed for Potential Treatments Against Drug Resistant Cancers Including HER2-Positive Metastatic Breast Cancer, Gastric Cancer, Lung Cancer and Ovarian Cancer
HER2 and HER3 Conformational Domain Bridging Epitopes in Antibodies via an Exclusive Option Allows Hillstream…
Clene Reports New Data from the VISIONARY-MS Phase 2 Study in Multiple Sclerosis Demonstrating CNM-Au8® Treatment Improved Brain Neuronal Structural Integrity
MRI results reinforce the clinical neurological improvements previously reported MRI results showed improved brain neuronal…
Aprea Therapeutics Announces One-for-Twenty Reverse Stock Split
DOYLESTOWN, Pa., Feb. 13, 2023 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE) (the “Company”), a…
BIO-key Partners with Europe’s Bravantic Group to Offer Transformative Identity Access Management Solutions in Europe, Africa, Brazil, and the Middle East
WALL, N.J. and LISBON, Portugal, Feb. 13, 2023 (GLOBE NEWSWIRE) — BIO-key International, Inc. (NASDAQ:…
Quark Launches New Partner Portal to Fuel Partner Ecosystem Growth
Marketing resources, support, training, financial incentives designed to uncover new revenue opportunities with content lifecycle…
Check Point Software Introduces Quantum SD-WAN to Protect Branch Offices Unifying Best Security and Optimized Internet Connectivity
Check Point Quantum SD-WAN provides comprehensive prevention against zero-day, phishing, and ransomware attacks and delivers…
Daview Talk (DVTC) Is Now Available for Trading on LBank Exchange
Road Town, British Virgin Islands–(Newsfile Corp. – February 13, 2023) – LBank Exchange, a global…